IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell ...

Company to highlight lead program CR-001, a tetravalent VEGF1 x PD-1 bispecific antibody in development for treating solid ...

Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will ...

TD Cowen's 45 th Annual Health Care Conference is taking place on March 3-5, 2025, at the Boston Marriott Copley Place in Boston, MA. The conference incorporates presentations, fireside chats and ...

Event: TD Cowen 45 th Annual Health Care Conference Location: Marriott Copley Place, Boston, MA Presentation: Tuesday, March 4, 3:10 p.m. EST Webcast: https://wsw.com/webcast/cowen177/huma/2017833 ...

About Avalyn Pharma. Avalyn is a biopharmaceutical company developing inhaled therapies for the treatment of rare respiratory ...

The webcast may also be accessed through Spero Therapeutics' website ( www.sperotherapeutics.com) on the "Events and ...

announced that it will participate in the 45th Annual TD Cowen Healthcare Conference including a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time. Interested investors and ...

today announced that it will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference to take place on March 3-5, 2025.

About atai Life Sciences atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. The Company was founded in response to the significant ...

today announced that the company will present at the TD Cowen 45 th Annual Health Care Conference on Wednesday, March 5, 2025, from 9:50 a.m. – 10:20 a.m. ET. Zhenya Lindgardt, President and CEO, will ...

today announced that Chief Executive Officer Ofer Gonen will present a corporate overview at the upcoming 45th Annual TD Cowen health Care Conference, taking place in Boston, MA on Wednesday ...